CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 49 enrolled
Drug / intervention
Ketorolac +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04246554
NCT04246554Phase 3Completed
CompareCT.gov

Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery

University Hospitals Cleveland Medical Center·interventional·Posted Jan 29, 2020·Updated Dec 21, 2021

In Brief

A Phase 3 clinical trial evaluating Ketorolac and Oxycodone-Acetaminophen for ACL Injury and Postoperative Pain. Completed, enrolled 49 participants across 1 site.

Detailed Summary

1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following ACL reconstruction surgery. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following ACL reconstruction surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsACL Injury, Postoperative Pain
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2020202120222023202420252026
First PostedJan 29, 2020
Enrollment StartMay 21, 2019
Primary CompletionOct 9, 2020
Study CompletionJan 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 6.4 years ago

Interventions

Ketorolacdrug

Oral ketorolac for pain control following ACL reconstruction surgery

Oxycodone-Acetaminophendrug

Oral oxycodone-acetaminophen for post-operative pain control